CRITICAL ASPECT ANALYTICAL TEST REVIEW · 2017. 12. 28. · Monitoring (EM), Microbial Limit Test...

24
CRITICAL ASPECT ANALYTICAL TEST REVIEW Jakarta 14 December 2017 Speaker: HERU PURNOMO, ST

Transcript of CRITICAL ASPECT ANALYTICAL TEST REVIEW · 2017. 12. 28. · Monitoring (EM), Microbial Limit Test...

  • CRITICAL ASPECT ANALYTICAL TEST REVIEW

    Jakarta 14 December 2017

    Speaker:

    HERU PURNOMO, ST

  • ispe.orgConnecting Pharmaceutical Knowledge 2

    Start

    Review Lab Result

    Submission

    Lab Record to QA

    Non Conformance or Out

    of Specification

    Investigation

    Meet Specification

    Stop

    Sample Received

    (In-Process & Finished

    Good)

    Testing

    BATCH DISPOSITION

    Yes

    No

    QC WORK FLOW

  • ispe.orgConnecting Pharmaceutical Knowledge 3

    Analytical Test Result

    Analytical Worksheet

    Analytical Report

    Certificate of Analysis

    (CoA)

    The analytical test report

    is a compilation of the

    results and states the

    conclusions of the

    examination of a sample

    Internal document to be

    used by the

    analyst for recording

    information about the

    sample, the test

    procedure,

    calculations and the

    results of testing. It is to

    be complemented by

    the raw data obtained in

    the analysis

    The list of test procedures

    applied to a particular

    sample with the results

    obtained and the

    acceptance criteria

    applied. It indicates

    whether or not the

    sample complies with the

    specification

  • ispe.orgConnecting Pharmaceutical Knowledge 4

    Certificate of Analysis (CoA)

    • A specification is defined as a list of tests, references to

    analytical procedures, and appropriate acceptance criteria that

    are numerical limits, ranges, or other criteria for the tests

    described

    • It establishes the set of criteria to which a drug substance or

    drug product should conform to be considered acceptable for

    its intended use. “Conformance to specifications” means that

    the drug substance and/or drug product, when tested according

    to the listed analytical procedures, will meet the listed

    acceptance criteria

  • ispe.orgConnecting Pharmaceutical Knowledge 5

    Review of Analytical Test Result

    Written procedure should be in place when reviewing analytical result with

    the following information:

    • Provide general guideline for checking of analytical raw data, worksheet

    and associated document in QC Lab

    • Applies to GMP analytical raw data in physical – chemical, microbiology

    and raw material

    • Preparation steps, observation and calculation step should be

    documented and show on the worksheet, these associated

    documentations have to be reviewed for completeness and accuracy as

    well

    • The date of execution and analyst / chemist / microbiologist who perform

    the testing is to be identified on worksheet

    • All printout of raw data should be attached to the analytical worksheet.

    Printout must signed or initialled across the edge of attachment

  • ispe.orgConnecting Pharmaceutical Knowledge 6

    HPLC / GC Chromatographic Test

    The following review for chromatographic data should be done for completeness

    and accuracy:

    1. Program setup:

    Flow rate, detector wavelength, column temperature, mobile phase (e.g.

    isocratic / gradient) & composition, need wash / seal wash setup

    2. Sequence Setup

    Injection Volume, Column ID, Sample Type, Sample Description, Sample

    Weight, Reference accuracy weight

    3. Integration Setup

    SST Setup, Reference Standard Weight Entry, retention setup and

    allowable window, proper integration peak

    4. Chromatogram

    Examine the blank chromatogram and note any extra peaks, particularly

    those that co-eluate with any peak interest

    5. Audit trail

    Check data integrity of sequence by verifying the audit trail for any

    unauthorized changes

  • ispe.orgConnecting Pharmaceutical Knowledge 7

    HPLC / GC Chromatographic Test (cont)

    6. Check the expiry of standard and test mix, use in the analysis, against the

    relevant reference material certificate or preparation. Ensure they are within

    the expiry date and preparation correct

    7. Check that specified system suitability result are met against the relevant

    testing method

    8. Check the accuracy of all values that are manually calculated

  • ispe.orgConnecting Pharmaceutical Knowledge 8

    Dissolution

    Check should be carried out on both the dissolution procedure and method

    analysis:

    1. Dissolution medium used and the operating temperature

    2. Type of Aparatus

    3. Preparation standard and sample

    4. Sampling procedure and technique (e.g. intervals, filtration, handling of

    samples, dilution)

    5. Calculations

    6. The blank and standard solution spectra or chromatograms supporting the

    dissolution test should either be available electronically or documented in lab

    worksheet

  • ispe.orgConnecting Pharmaceutical Knowledge 9

    Microbiological Testing for Water, Environment

    Monitoring (EM), Microbial Limit Test (MLT)

    1. Check that the analytical worksheet and SOP used were correct and the

    sampling points were accurately recorded. Check the presence and

    accuracy of the following minimum information:

    • Date of sampling / performed date of testing

    • Date of reading plate / result recording date

    • Indicate the lot reference and expiry date of media used and verified that

    the lot reference used is within expiry date at point of usage

    • Date and temperature of incubation

    • Equipment ID and ensure equipment are still within their qualification /

    calibration status at point of usage

    • Test result of negative or positive control which was carried out in

    accordance to the test method

    • Water sampling point (for microbiological testing for water) / legend (for

    environment monitoring)

    • Initial of analyst & reviewer and date

    2. Check the result against the acceptance criteria in the relevant test

    procedure

  • ispe.orgConnecting Pharmaceutical Knowledge 10

    Other Tests

    Hard copy, generated from test (for example: UV, infrared absorption)

    should bear the following information:

    Initial / name of analyst

    • Sample Identity

    • Instrument Number

    • Spectrum (where applicable)

    • Testing date

    • Instrument Parameter (where applicable)

    • Result / data obtained

  • ispe.orgConnecting Pharmaceutical Knowledge 11

    Tolerance Limit & Specification Check

    • If the test method requires tolerance limit check for the replicate

    runs, check the replicate value against the pre-defined tolerance

    limit in the test method

    • Check the reported results against specification and trend limit (if

    any)

    • The review period of a GMP analytical result should be recorded in a

    timely manner (e.g. 24 working hours from the test completion date)

  • ispe.orgConnecting Pharmaceutical Knowledge 12

    Trend Rule Violation – Out of Trend

    There are three (3) trend rule violations:

    1. Result out of trend limits

    2. Nine (9) or more consecutive data points shifted above or below the center line

    3. Six (6) or more data points consecutively increasing or decreasing

  • ispe.orgConnecting Pharmaceutical Knowledge 13

    OUT OF TREND (OOT) - NELSON TEST

    Rule # 1

    Any point outside

    control limit

    Rule # 2

    9 consecutive point on

    same side centreline

    Rule # 3

    6 consecutive point

    decreasing or

    increasing

  • ispe.orgConnecting Pharmaceutical Knowledge 14

    What is an Audit Trail?

    1. Systematic “story” of the data from creation, through interpretation

    and final assessment and report

    2. Each functional area that have GxP computer systems need to

    perform audit trail

    3. The information should be recorded in Audit Trail:

    • Date and Time

    • Name of person making change

    • Original Change and value

    • Reason of change made

    • Invalid attempts to log on the system

    If audit trail procedure is not available, the company has no

    possibility to detect violations to data integrity executed by site

    Operators due to errors / malfeasances, unintended or deliberate

  • ispe.orgConnecting Pharmaceutical Knowledge 15

    Regulatory Guidance for Audit Trail Review

  • ispe.orgConnecting Pharmaceutical Knowledge 16

    Audit Trail Review

    • Evaluation of process risk associated to the system intended use

    • An assessment must be performed for each system in order to

    identify the most adequate method

  • ispe.orgConnecting Pharmaceutical Knowledge 17

    Audit Trail Review

    Risk class identification to define critical point:

    • Frequency of audit trail

    • Sampling Plan: The number of record to be reviewed

  • ispe.orgConnecting Pharmaceutical Knowledge 18

    Audit Trail Review

    Create form to define the

    verification to be executed

    and the relevant

    acceptance criteria

  • ispe.orgConnecting Pharmaceutical Knowledge 19

    Common Question During Inspection

    • Is the audit trail activated? SOP?

    • Record of review?

    • How to prevent or detect any deletion of modification of audit trail

    data? Training staff?

    • Is predicate rule principle followed for changed?

    Preserve of original data

    Corrected data

    Date of correction

    Name of person who correction the data

    Justification comment for correction

    • What if there is no audit trail function?

    • Can you prove data manipulation did not occur?

  • ispe.orgConnecting Pharmaceutical Knowledge 20

  • ispe.orgConnecting Pharmaceutical Knowledge 21

  • ispe.orgConnecting Pharmaceutical Knowledge 22

    QA Responsibility

    Do I need to review Analytical test result?

    System & Facility

    Culture

    Confident

    • Create robust procedure to review analytical test

    result

    • Qualified personnel

    • Allocate budget to reduce potential data integrity

    issue

    • Develop management practises and supervision to

    encourage reporting problem

    • Identify root causes without finger pointing

    Random check based on risk assessment

    approach

  • ispe.orgConnecting Pharmaceutical Knowledge

    http://thegledaproject.com/thank-you/http://thegledaproject.com/thank-you/

  • ispe.orgConnecting Pharmaceutical Knowledge